Voveran Side Effects

6609769-9 | Conjunctival Hyperaemia, Corneal Oedema, Corneal Perforation, Corneal Thinning, Eye Pain, Lacrimation Increased, Ocular Hyperaemia
on Feb 15, 2010 Male patient from INDIA , 19 years of age, was treated with Voveran Ophthalmic (nvo)(View Usage). Patient experienced the following unwanted or unexpected effects: conjunctival hyperaemia, corneal oedema, corneal perforation, corneal thinning, eye pain, lacrimation increased, ocular hyperaemia. Voveran Ophthalmic (nvo) dosage: 0.1 %, 5 Times In A Day. During the same period patient was treated with DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), PROPARACAINE HCL (Unk) (View Proparacaine Hcl Review and Proparacaine Hcl Label ), OFLOXACIN (View Ofloxacin Review and Ofloxacin Label ), RIBOFLAVIN TAB (View Riboflavin Tab Review and Riboflavin Tab Label ), ANTIINFL. PREP., NON STEROIDS FOR TOPICAL USE (View Antiinfl. Prep., Non-steroids For Topical Use Review and Antiinfl. Prep., Non-steroids For Topical Use Label ), CARBOXYMETHYLCELLULOSE SODIUM (4 Times A Day In Both Eyes) (View Carboxymethylcellulose Sodium Review and Carboxymethylcellulose Sodium Label ).

5405689-6 | Injection Site Erythema, Injection Site Induration
Patient was taking Voveran (View Usage). Patient had the following side effects: injection site erythema, injection site induration on Jul 30, 2007 from INDIA Additional patient health information: Female patient , 30 years of age, was diagnosed with pain (What is pain?) and. Voveran dosage: . During the same period patient was treated with HYDROXYCHLOROQUINE SULFATE (View Hydroxychloroquine Sulfate Review and Hydroxychloroquine Sulfate Label ), MEXATE (View Mexate Review and Mexate Label ).

5405682-3 | Injection Site Erythema, Injection Site Induration
Adverse event was reported on Jul 30, 2007 by a Male patient taking Voveran (View Usage) (Dosage: ) . Location: INDIA , 53 years of age, After Voveran was administered, patient had the following side effects: injection site erythema, injection site induration. During the same period patient was treated with TRAMADOL HCL (View Tramadol Hcl Review and Tramadol Hcl Label ), CEFUROXIME (View Cefuroxime Review and Cefuroxime Label ), GENTAMICIN (View Gentamicin Review and Gentamicin Label ).

5405617-3 | Injection Site Erythema, Injection Site Induration
on Jul 30, 2007 Female patient from INDIA , 22 years of age, was diagnosed with pain (What is pain?) and was treated with Voveran (View Usage). Patient experienced the following unwanted or unexpected effects: injection site erythema, injection site induration. Voveran dosage: . During the same period patient was treated with CEFUROXIME (View Cefuroxime Review and Cefuroxime Label ), GENTAMICIN (View Gentamicin Review and Gentamicin Label ).


5398894-9 | Cough, Dyspnoea, Macroglossia, Palpitations, Pruritus, Rash
on Jul 23, 2007 Male patient from INDIA , 63 years of age, was diagnosed with back pain (What is back pain?) and was treated with Voveran(View Usage). Patient had the following side effects: cough, dyspnoea, macroglossia, palpitations, pruritus, rash (What is rash?). Voveran dosage: 50 Mg, Qd.

5303137-8 | Blood Pressure Decreased, Eye Pruritus, Feeling Abnormal, Ocular Hyperaemia, Pulse Abnormal, Restlessness
Patient was taking Voveran Plus (View Usage). After Voveran was administered, patient had the following side effects: blood pressure decreased, eye pruritus, feeling abnormal, ocular hyperaemia, pulse abnormal, restlessness on Apr 13, 2007 from INDIA Additional patient health information: Female patient , 62 years of age, . Voveran Plus dosage: Diclo 50 / Para 500 Mg/day. During the same period patient was treated with PARACETAMOL (1 Ml/day) (View Paracetamol Review and Paracetamol Label ).

5157214-5 | Radial Nerve Palsy
Adverse event was reported on Nov 15, 2006 by a Female patient taking Voveran (View Usage) (Dosage: 3 Ml, Unk) was diagnosed with back pain (What is back pain?) and. Location: INDIA , 30 years of age, Patient experienced the following unwanted or unexpected effects: radial nerve palsy.

5153082-6 | Haemoglobin Decreased, Otorrhoea, Tympanic Membrane Perforation
on Nov 08, 2006 Male patient from INDIA , 56 years of age, was diagnosed with musculoskeletal pain and was treated with Voveran (View Usage). Patient had the following side effects: haemoglobin decreased, otorrhoea, tympanic membrane perforation. Voveran dosage: 100 Mg/day. During the same period patient was treated with LOPRIL (View Lopril Review and Lopril Label ), WYSOLONE (5 Mg, Unk) (View Wysolone Review and Wysolone Label ), XANTINOL NICOTINATE (View Xantinol Nicotinate Review and Xantinol Nicotinate Label ).

5125015-X | Circulatory Collapse, Dizziness, Dyspnoea, Pruritus
on Oct 07, 2006 Male patient from INDIA , 72 years of age, was diagnosed with arthralgia and was treated with Voveran(View Usage). After Voveran was administered, patient had the following side effects: circulatory collapse, dizziness (What is dizziness?), dyspnoea, pruritus. Voveran dosage: 3 Ml, Once/single. During the same period patient was treated with GENTAMICIN (2 Ml, Unk) (View Gentamicin Review and Gentamicin Label ).

5044309-X | Abdominal Pain Upper, Ileus Paralytic
Patient was taking Voveran (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain upper, ileus paralytic on Jun 24, 2006 from INDIA Additional patient health information: Female patient , 22 years of age, was diagnosed with procedural pain and. Voveran dosage: Two Injection At A Gap Of 15 Hours. During the same period patient was treated with RANITIDINE (View Ranitidine Review and Ranitidine Label ), PANTOPRAZOLE (View Pantoprazole Review and Pantoprazole Label ), KETAMINE HCL (View Ketamine Hcl Review and Ketamine Hcl Label ). Patient was hospitalized.

5042453-4 | Asthenia, Dizziness, Erythema, Feeling Cold, Flushing, Hypotension, Nausea, Pruritus
Adverse event was reported on Jun 23, 2006 by a Female patient taking Voveran (View Usage) (Dosage: ) was diagnosed with pain (What is pain?) and. Location: INDIA , 60 years of age, Patient had the following side effects: asthenia, dizziness (What is dizziness?), erythema, feeling cold, flushing, hypotension, nausea (What is nausea?), pruritus. During the same period patient was treated with AVIL (View Avil Review and Avil Label ), DEXONA (View Dexona Review and Dexona Label ), ADRENALINE (0.5 Ml, Unk) (View Adrenaline Review and Adrenaline Label ). Patient was hospitalized.

4987043-4 | Erythema, Injection Site Swelling, Rash
on Apr 03, 2006 Male patient from INDIA , 55 years of age, was treated with Voveran (View Usage). After Voveran was administered, patient had the following side effects: erythema, injection site swelling, rash (What is rash?). Voveran dosage: . During the same period patient was treated with MONOCEF (View Monocef Review and Monocef Label ), AMIKACIN (View Amikacin Review and Amikacin Label ), FENERGAN (View Fenergan Review and Fenergan Label ).

4971476-6 | Erythema, Injection Site Swelling, Rash
on Apr 03, 2006 Male patient from INDIA , 55 years of age, was treated with Voveran(View Usage). Patient experienced the following unwanted or unexpected effects: erythema, injection site swelling, rash (What is rash?). Voveran dosage: . During the same period patient was treated with MONOCEF (View Monocef Review and Monocef Label ), AMIKACIN (View Amikacin Review and Amikacin Label ), FENERGAN (View Fenergan Review and Fenergan Label ).

4714451-9 | Corneal Epithelium Defect
Patient was taking Voveran Ophthalmic (nvo) (View Usage). Patient had the following side effects: corneal epithelium defect on Jul 04, 2005 from INDIA Additional patient health information: Male patient , 58 years of age, was diagnosed with inflammation, prophylaxis and. Voveran Ophthalmic (nvo) dosage: Unk, Qid. During the same period patient was treated with PREDNISOLONE ACETATE (View Prednisolone Acetate Review and Prednisolone Acetate Label ).

4714446-5 | Corneal Epithelium Defect
Adverse event was reported on Jul 04, 2005 by a Male patient taking Voveran Ophthalmic (nvo) (View Usage) (Dosage: Unk, Qid) . Location: INDIA , 28 years of age, After Voveran was administered, patient had the following side effects: corneal epithelium defect. During the same period patient was treated with PREDNISOLONE ACETATE (View Prednisolone Acetate Review and Prednisolone Acetate Label ), TIMOLET P (View Timolet P Review and Timolet P Label ).

4714445-3 | Corneal Perforation, Ulcerative Keratitis
on Jul 04, 2005 Female patient from INDIA , 80 years of age, was treated with Voveran Ophthalmic (nvo) (View Usage). Patient experienced the following unwanted or unexpected effects: corneal perforation, ulcerative keratitis. Voveran Ophthalmic (nvo) dosage: Unk, Qid. During the same period patient was treated with PREDNISOLONE ACETATE (View Prednisolone Acetate Review and Prednisolone Acetate Label ), ANTIGLAUCOMA PREPARATIONS AND MIOTICS (View Antiglaucoma Preparations And Miotics Review and Antiglaucoma Preparations And Miotics Label ).

4714444-1 | Corneal Epithelium Defect
on Jul 04, 2005 Male patient from INDIA , 58 years of age, was diagnosed with post procedural complication and was treated with Voveran Ophthalmic (nvo)(View Usage). Patient had the following side effects: corneal epithelium defect. Voveran Ophthalmic (nvo) dosage: Unk, Qid. During the same period patient was treated with PREDNISOLONE ACETATE (View Prednisolone Acetate Review and Prednisolone Acetate Label ).

4714442-8 | Corneal Epithelium Defect
Patient was taking Voveran Ophthalmic (nvo) (View Usage). After Voveran was administered, patient had the following side effects: corneal epithelium defect on Jul 04, 2005 from INDIA Additional patient health information: Male patient , 70 years of age, . Voveran Ophthalmic (nvo) dosage: Unk, Qid. During the same period patient was treated with PREDNISOLONE ACETATE (View Prednisolone Acetate Review and Prednisolone Acetate Label ).

4669915-3 | Gastrointestinal Haemorrhage, Haematemesis
Adverse event was reported on May 16, 2005 by a Male patient taking Voveran (View Usage) (Dosage: 50 Mg, Bid) was diagnosed with femur fracture and. Location: , 76 years of age, Patient experienced the following unwanted or unexpected effects: gastrointestinal haemorrhage, haematemesis. During the same period patient was treated with TAXIM (1 G, Bid) (View Taxim Review and Taxim Label ), GENTAMICIN (80 Mg, Bid) (View Gentamicin Review and Gentamicin Label ), RANTAC (150 Mg, Qd) (View Rantac Review and Rantac Label ), CARBAMAZEPINE (100 Mg/day) (View Carbamazepine Review and Carbamazepine Label ). Patient was hospitalized.

4644689-0 | Dizziness, Ecg Signs Of Myocardial Ischaemia, Hypotension, Pruritus, Pulse Absent, Rash
on Apr 21, 2005 Female patient from , 70 years of age, was diagnosed with periarthritis and was treated with Voveran (View Usage). Patient had the following side effects: dizziness (What is dizziness?), ecg signs of myocardial ischaemia, hypotension, pruritus, pulse absent, rash (What is rash?). Voveran dosage: 75 Mg, Once/single. Patient was hospitalized.

4556074-0 | Abasia, Asthenia, Gait Disturbance, Hypoaesthesia
on Dec 29, 2004 Male patient from , 34 years of age, was diagnosed with pain (What is pain?) and was treated with Voveran(View Usage). After Voveran was administered, patient had the following side effects: abasia, asthenia, gait disturbance, hypoaesthesia. Voveran dosage: 75 Mg, Once/single.

4556073-9 | Abasia, Asthenia, Hypoaesthesia, Paraesthesia
Patient was taking Voveran (View Usage). Patient experienced the following unwanted or unexpected effects: abasia, asthenia, hypoaesthesia, paraesthesia on Dec 28, 2004 from Additional patient health information: Male patient , 48 years of age, was diagnosed with back pain (What is back pain?) and. Voveran dosage: 75 Mg, Once/single.

4546308-0 | Abasia, Asthenia, Hypoaesthesia
Adverse event was reported on Dec 29, 2004 by a Male patient taking Voveran (View Usage) (Dosage: 75 Mg, Once/single) was diagnosed with pain (What is pain?) and. Location: , 34 years of age, Patient had the following side effects: abasia, asthenia, hypoaesthesia.

4546306-7 | Abasia, Asthenia, Hypoaesthesia, Paraesthesia
on Dec 28, 2004 Male patient from , 48 years of age, was diagnosed with back pain (What is back pain?) and was treated with Voveran (View Usage). After Voveran was administered, patient had the following side effects: abasia, asthenia, hypoaesthesia, paraesthesia. Voveran dosage: 75 Mg, Once/single.